Navigation Links
Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
Date:8/13/2013

LOUISVILLE, Ky., Aug. 13, 2013 /PRNewswire-iReach/ -- In collaboration with the James Graham Brown Cancer Center at the University of Louisville, LBIdx™ is advancing a breakthrough blood test, the Plasma Thermogram™ (pT). Based on a simple blood draw, researchers at LBIdx™ and the Brown Cancer Center see great promise for the pTtest as a "game-changer" allowing physicians to monitor cancer patients more closely. Monitoring is a critical part of cancer treatment and provides physicians with vital information in the fight against cancer.

LBIdx™ and the Brown Cancer Center are initiating a clinical study that will demonstrate the pT test's capabilities for improved monitoring of melanoma patients at dangerous risk of metastasis and for response to medical treatment. Director Donald Miller M.D., Ph.D. and Deputy Director Jason A. Chesney, M.D., Ph.D., will be co-investigators of the planned study to detect earlier signs of change in disease status. Researchers expect the pTwill provide a unique insight into cancer status leading to improved medical response options, including therapy. Equally important, this test stands to be an earlier indicator or remission or relapse.  In all, the test stands to help answer those age-old questions, "Am I winning my battle with cancer?" and "Is my cancer gone?" 

Current medical practice frequently relies on medical imaging procedures, like CT scans, to monitor melanoma patients. But due to the high dose radiation exposure from each procedure, their use by physicians is limited, which can hinder patient monitoring.  In addition, the FDA is striving to reduce unnecessary radiation exposure from these medical imaging procedures which are the greatest contributors to total radiation exposure within the U.S.

Alfred "Ben" Jenson, Professor of Vaccinology at the James Graham Brown Cancer Center and co-inventor of the pThas been a strong supporter of the pT's cancer monitoring potential.  Ben is also known for his work as co-inventor of the cervical cancer vaccine, Gardasil, and sees potential for the pT as a monitoring tool for a multitude of cancers, including difficult-to-detect oral cancers.

LBIdx™ is a start-up company, focused on the commercialization of pT tests for cancer monitoring and prognosis. It is currently raising funds via a crowd funding campaign allowing the public, who will benefit from such a test, to support this enhanced cancer monitoring effort. Crowd funding is a relatively new concept approved by the U.S. Jobs Act of 2012. Details of their 'Breakthrough in Cancer Detection & Monitoring' campaign can be found on the Indiegogo crowd funding website using the following link, http://igg.me/at/CancerDetectionStudy.

About Louisville Bioscience, Inc.

LBIdx™, headquartered in Louisville, Kentucky, is a start-up company with an exclusive license to the University of Louisville Plasma Thermogram™ (pT) technology and focused on the commercialization of pT tests for cancer monitoring and prognosis.  The novel pT blood test can provide earlier detection of disease, effectively assess status of cancer remission and improve monitoring in response to therapy for numerous cancers including: melanoma, breast, cervical, ovarian and lung cancers. The pT diagnostic platform utilizes Differential Scanning Calorimetry (DSC) to generate a robust temperature-induced melting profile of the major blood proteins. The LBIdx™ core technology was invented by the University of Louisville team of Dr. Jonathan Chaires (James Graham Brown Endowed Chair of Cancer Biophysics), Dr. Nichola Garbett and Dr. Alfred "Ben" Jenson. For more information, please visit www.lbidx.com

Media Contact: Michael Birdsell, LBIdx, 502.414.1243, mbirdsell@lbidx.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE LBIdx
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Cloud-Based Investigator Portal from Veeva Systems Speeds Clinical Study Start-Up
2. Structure-Based Drug Design Conference in Boston, Starting June 19 PLUS These 62 Start-ups and Small Companies Will Transform Drug Delivery Technology
3. Janssen Labs at San Diego Expands to Add Concept Lab and Open Collaboration Space to Accommodate Individual Entrepreneurs and Additional Life Science Start-Ups
4. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
5. Helping Start-Ups Avoid Slow-Downs
6. Fuisz Pharma Announces Intent to Divest Strategic Patent for Detection of Opioid Abuse; Seeks Offers for Patent through May 2013
7. $1,000,000 Global B.R.A.I.N. Prize Seeks Applicants
8. American Academy of Pain Medicine Reacts to PROP Petition to the FDA that Seeks to Limit Pain Medications for Legitimate Noncancer Pain Sufferers
9. Searcy Denney Scarola Barnhart & Shipley PA Seeks Damages Caused by Recalled Product
10. Separation Design Group Launches Crowd-Funding Campaign for Worlds Smallest Oxygen Machine
11. Prosum Kicks Off Crowd Funding for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology:
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
Breaking Medicine News(10 mins):